HA TECH is an Australian company specializing in innovative diagnostic and pharmaceutical solutions for global health challenges. Focused on early detection of infectious diseases such as respiratory illnesses, STIs, mosquito-borne diseases, and cancer, the company aims to enhance diagnosis and treatment. It also develops pharmaceuticals, including short- and long-acting insulin and GLP receptor agonists for obesity. With Australia's largest diagnostic manufacturing capacity—producing 40 million RT-PCR and 10 million rapid antigen test kits monthly—HA TECH is committed to improving healthcare outcomes worldwide through its advanced solutions and manufacturing expertise.

Why work with us

• Our diagnostic portfolio covers a wide range of diseases, enabling comprehensive detection and management across diverse health conditions.
• Our Point of Care / home test kits are built on unique, patented technology that ensures ease of use and exceptionally high sensitivity for accurate results.
• Our universal RT-PCR kits are compatible with any PCR machine and are supported by our AI-powered automated software, making result interpretation simple and reliable.
• We provide dedicated global customer support to ensure seamless service and technical assistance worldwide.
• We actively pursue research collaborations with some of the world’s leading universities and research organizations to address major global health challenges.
• Our pipeline includes innovative pharmaceutical products such as insulin analogues and GLP receptor agonists, reinforcing our commitment to advancing healthcare solutions.